Skip to main content

Table 2 The combination of ADA and TL status

From: Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

  Normal TL Low TL
ADA negative 58% 21.4%
ADA positive 10.7% 9.8%
  1. (ADA Anti-drug antibody, TL Trough level)